DK1034171T3 - Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid - Google Patents

Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid

Info

Publication number
DK1034171T3
DK1034171T3 DK98956725T DK98956725T DK1034171T3 DK 1034171 T3 DK1034171 T3 DK 1034171T3 DK 98956725 T DK98956725 T DK 98956725T DK 98956725 T DK98956725 T DK 98956725T DK 1034171 T3 DK1034171 T3 DK 1034171T3
Authority
DK
Denmark
Prior art keywords
piperazinyl
fluorophenyl
ethoxy
bis
methyl
Prior art date
Application number
DK98956725T
Other languages
Danish (da)
English (en)
Inventor
Monique Berwaer
Guy Bodson
Michel Deleers
Charles Dogimont
Domenico Fanara
Jacques Timmermans
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of DK1034171T3 publication Critical patent/DK1034171T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK98956725T 1997-11-26 1998-11-26 Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid DK1034171T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (fr) 1997-11-26 1997-11-26 Formes pseudopolymorphiques de l'acide 2-2-4-bis(4-fluorophényl)méthyl -1-pipérazinyl-éthoxy acétique dihydrochloride
PCT/BE1998/000184 WO1999028310A1 (fr) 1997-11-26 1998-11-26 Formes pseudomorphes de dichlorhydrate d'acide 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetique

Publications (1)

Publication Number Publication Date
DK1034171T3 true DK1034171T3 (da) 2001-11-05

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98956725T DK1034171T3 (da) 1997-11-26 1998-11-26 Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid

Country Status (39)

Country Link
US (2) US6262057B1 (fr)
EP (2) EP0919550A1 (fr)
JP (2) JP3996348B2 (fr)
KR (1) KR100557711B1 (fr)
CN (1) CN100406448C (fr)
AR (1) AR017676A1 (fr)
AT (1) ATE203237T1 (fr)
AU (1) AU735819B2 (fr)
BG (1) BG64155B1 (fr)
BR (1) BR9815405A (fr)
CA (1) CA2310318C (fr)
CO (1) CO4980892A1 (fr)
CZ (1) CZ295972B6 (fr)
DE (1) DE69801163T2 (fr)
DK (1) DK1034171T3 (fr)
EG (1) EG23776A (fr)
ES (1) ES2161552T3 (fr)
GC (1) GC0000094A (fr)
GR (1) GR3036702T3 (fr)
HU (1) HUP0100343A3 (fr)
ID (1) ID24964A (fr)
IL (1) IL135544A (fr)
MA (1) MA26569A1 (fr)
MY (1) MY119653A (fr)
NO (1) NO314692B1 (fr)
NZ (1) NZ504461A (fr)
PE (1) PE134899A1 (fr)
PL (1) PL190871B1 (fr)
PT (1) PT1034171E (fr)
RS (1) RS49904B (fr)
RU (1) RU2182575C2 (fr)
SI (1) SI20325A (fr)
SK (1) SK283237B6 (fr)
TN (1) TNSN98214A1 (fr)
TR (1) TR200001505T2 (fr)
TW (1) TWI225053B (fr)
UA (1) UA54568C2 (fr)
WO (1) WO1999028310A1 (fr)
ZA (1) ZA9810780B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047689A2 (fr) * 2000-12-15 2002-06-20 Ucb, S.A. Methode pour empecher l'urticaire
EP1414460A1 (fr) * 2001-07-26 2004-05-06 Ucb, S.A. Procede de fabrication de derives d'acides 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazine-1-yl)ethoxy)acetiques ou de sels de ces composes et intermediaires correspondants
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
JP2007500197A (ja) * 2003-05-28 2007-01-11 ユセベ ファルシム ソシエテ アノニム 持続性アレルギー性鼻炎の治療のためのエフレチリジンの使用
WO2006050909A1 (fr) * 2004-11-10 2006-05-18 Ucb Farchim Sa Nouvelles formes du dichlorhydrate d’efletirizine, procédés de synthèse desdites formes et préparations pharmaceutiques les incluant
WO2008155777A2 (fr) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Procédé de préparation de l'efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
ZA82752B (en) * 1981-02-06 1982-12-29 Ucb Sa 2-(4-(diphenylmethyl)-1-piperazinyl)-acetic acids and their amides
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.

Also Published As

Publication number Publication date
JP3996348B2 (ja) 2007-10-24
RS49904B (sr) 2008-08-07
BG104424A (en) 2001-01-31
JP2007224042A (ja) 2007-09-06
BG64155B1 (bg) 2004-02-27
AU1327799A (en) 1999-06-16
TWI225053B (en) 2004-12-11
MA26569A1 (fr) 2004-12-20
US20010021712A1 (en) 2001-09-13
CN100406448C (zh) 2008-07-30
AR017676A1 (es) 2001-09-12
GR3036702T3 (en) 2001-12-31
EP1034171A1 (fr) 2000-09-13
PL190871B1 (pl) 2006-02-28
IL135544A0 (en) 2001-05-20
PL340724A1 (en) 2001-02-26
SI20325A (sl) 2001-02-28
BR9815405A (pt) 2000-10-10
CO4980892A1 (es) 2000-11-27
MY119653A (en) 2005-06-30
EP1034171B1 (fr) 2001-07-18
ATE203237T1 (de) 2001-08-15
CZ295972B6 (cs) 2005-12-14
CN1279676A (zh) 2001-01-10
US6262057B1 (en) 2001-07-17
PE134899A1 (es) 2000-01-11
AU735819B2 (en) 2001-07-19
TR200001505T2 (tr) 2000-09-21
KR20010032420A (ko) 2001-04-16
EP0919550A1 (fr) 1999-06-02
HUP0100343A3 (en) 2001-09-28
DE69801163D1 (en) 2001-08-23
NO20002631D0 (no) 2000-05-23
UA54568C2 (uk) 2003-03-17
EG23776A (en) 2007-08-08
US6335331B2 (en) 2002-01-01
NZ504461A (en) 2001-06-29
NO314692B1 (no) 2003-05-05
NO20002631L (no) 2000-05-23
ZA9810780B (en) 1999-05-31
GC0000094A (en) 2005-06-29
ID24964A (id) 2000-08-31
SK283237B6 (sk) 2003-04-01
KR100557711B1 (ko) 2006-03-07
RU2182575C2 (ru) 2002-05-20
DE69801163T2 (de) 2002-03-28
JP2001524548A (ja) 2001-12-04
CZ20001787A3 (cs) 2000-09-13
IL135544A (en) 2004-02-08
ES2161552T3 (es) 2001-12-01
WO1999028310A1 (fr) 1999-06-10
SK5942000A3 (en) 2000-10-09
CA2310318A1 (fr) 1999-06-10
CA2310318C (fr) 2003-10-21
TNSN98214A1 (fr) 2005-03-15
HUP0100343A2 (hu) 2001-07-30
PT1034171E (pt) 2001-11-30
YU31600A (sh) 2002-03-18

Similar Documents

Publication Publication Date Title
EE200900043A (et) Tert-butl-(E)-(6-{2-[4-(4-fluorofenl)-6-isopropl-2-[metl(metlsulfonl)amino] primidiin-5-l]vinl}(4R, 6S)-2,2-dimetl[1,3]dioksaan-4-l)atsetaadi valmistamismeetod
DK1077943T3 (da) Heterocykliske inhibitorer af p38
DK1216239T3 (da) Antagonister af piperazin-derivater AS 5-HT1B
DK1237854T3 (da) Pulveriseret form af (S)-2-ethoxy-3-[4-(2-(4-methan sulfonyloxyphenyl)ethoxy)phenyl]propanonsyre
NO20100667L (no) Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater
DK1034171T3 (da) Pseudopolymorfe former af 2-[2-[4-[bis(4-fluorphenyl)-methyl]-1-piperazinyl]ethoxy]eddikesyre-dihydrochlorid
DK0927173T3 (da) Substituerede [2-(1-piperazinyl)ethoxy]methylforbindelser
BR9609849A (pt) Derivados de 2-(4-substituída)-benzilamino-2-metila-propanamid a
AR028281A1 (es) Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona
KR970707115A (ko) 플루오로퀴놀론의 물리적으로 안정한 신규한 고체 형태(a new physically stable solid form of a fluoroquinolone)
NO995938L (no) Blanding omfattende 5-[4-[2-(N-metyl-N-2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
DK1055658T3 (da) Fremstilling af cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphtalen-1-yl)phenoxy]ethyl-pyrrolidin
FI20001721L (fi) 6-hydroksi-3-(4-(/2-(piperidin-1-yyli)etoksi)fenoksi)-2-(4-metoksifenyyli)bentso(b)tiofeenihydrokloridin uusin kiteinen muoto
EE05609B1 (et) Dibensotiasepiiniderivaatide valmistamismeetod
NO992268D0 (no) N-bundne sulfonamider av heterocykliske tioestere
DK0952153T3 (da) Fremgangsmåde til fremstilling af estere af [2-[4-[(4-chlorphenyl)phenylmethyl]-1-piperazinyl]-ethoxy]eddikesyre
BR9603916A (pt) Derivados de ácido 2-(pirazolióxi-pirimidin-5-il) acético
NO995841L (no) Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2- fenylpropionsyre-derivater
ID27591A (id) Proses pembuatan isoprop l-metil-[2-(3-n-propoksi-fenoksi) etil] amina
DK0971919T3 (da) Fremgangsmåde til fremstilling af 4H-4-oxo-quinolizin-3-carboxylsyrederivater
DK1202967T3 (da) Svovlsyre-mono- [3- ({12- (4-fluorphenyl)ethyl]-piperidin-4-yl}hydrowymethyl)-2-methoxyphenylester
IS5544A (is) Nýtt fosfatsalt af ísóprópýl-metýl-[2-(3-n-própoxýfenoxý)-etýl]amíni
DK1214309T3 (da) Fremstilling af amidiner afledt af 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylsyre